Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | 0 | uM | 9 | 156.25 | 92.36 | 89.00 | 123.25 | 0.7221 | -0.0853 | |
| SK-BR-3 | Linsitinib | 19.9526 | uM | 9 | 156.25 | 92.36 | 101.00 | 123.25 | 0.8195 | 0.2396 |
| SK-BR-3 | Linsitinib | 3.1623 | uM | 9 | 156.25 | 92.36 | 95.00 | 123.25 | 0.7708 | 0.0700 |
| SK-BR-3 | Lapatinib | 0.0033113 | uM | 9 | 156.25 | 92.36 | 172.00 | 123.25 | 1.3955 | 3.4546 |
| SK-BR-3 | Erlotinib | 0.0033113 | uM | 9 | 156.25 | 92.36 | 184.00 | 123.25 | 1.4929 | 4.2382 |
| SK-BR-3 | Linsitinib | 0.1 | uM | 9 | 156.25 | 92.36 | 168.00 | 123.25 | 1.3631 | 3.2097 |
| SK-BR-3 | Lapatinib | 0.1 | uM | 9 | 156.25 | 92.36 | 75.00 | 123.25 | 0.6085 | -0.3937 |
| SK-BR-3 | 0 | uM | 9 | 156.25 | 92.36 | 150.00 | 123.25 | 1.2170 | 2.2062 | |
| SK-BR-3 | 17-AAG | 0.000066069 | uM | 9 | 156.25 | 92.36 | 144.00 | 123.25 | 1.1684 | 1.9067 |
| SK-BR-3 | 0 | uM | 9 | 156.25 | 92.36 | 180.00 | 123.25 | 1.4604 | 3.9687 | |
| SK-BR-3 | Linsitinib | 0.01 | uM | 9 | 156.25 | 92.36 | 212.00 | 123.25 | 1.7201 | 6.3620 |
| SK-BR-3 | 17-AAG | 0.1 | uM | 9 | 156.25 | 92.36 | 103.00 | 123.25 | 0.8357 | 0.2994 |
| SK-BR-3 | Lapatinib | 0.01 | uM | 9 | 156.25 | 92.36 | 209.00 | 123.25 | 1.6957 | 6.1141 |
| SK-BR-3 | Lapatinib | 0.31623 | uM | 9 | 156.25 | 92.36 | 102.00 | 123.25 | 0.8276 | 0.2693 |
| SK-BR-3 | 17-AAG | 0.31623 | uM | 9 | 156.25 | 92.36 | 54.00 | 123.25 | 0.4381 | -0.7246 |
| SK-BR-3 | Erlotinib | 0.1 | uM | 9 | 156.25 | 92.36 | 96.00 | 123.25 | 0.7789 | 0.0972 |
| SK-BR-3 | 0 | uM | 9 | 156.25 | 92.36 | 133.00 | 123.25 | 1.0791 | 1.4015 | |
| SK-BR-3 | Erlotinib | 19.9526 | uM | 9 | 156.25 | 92.36 | 267.00 | 123.25 | 2.1663 | 11.8141 |
| SK-BR-3 | Lapatinib | 0.031623 | uM | 9 | 156.25 | 92.36 | 115.00 | 123.25 | 0.9331 | 0.6933 |
| SK-BR-3 | Lapatinib | 0.0016596 | uM | 9 | 156.25 | 92.36 | 97.00 | 123.25 | 0.7870 | 0.1249 |
| SK-BR-3 | 17-AAG | 0.031623 | uM | 9 | 156.25 | 92.36 | 71.00 | 123.25 | 0.5761 | -0.4685 |
| SK-BR-3 | 0 | uM | 9 | 156.25 | 92.36 | 124.00 | 123.25 | 1.0061 | 1.0294 | |
| SK-BR-3 | 0 | uM | 9 | 312.50 | 200.50 | 309.00 | 350.25 | 0.8822 | 0.7116 | |
| SK-BR-3 | Erlotinib | 0.01 | uM | 9 | 312.50 | 200.50 | 395.00 | 350.25 | 1.1278 | 1.3223 |
| SK-BR-3 | 17-AAG | 0.000302 | uM | 9 | 312.50 | 200.50 | 357.00 | 350.25 | 1.0193 | 1.0480 |